Compare Moderna, Inc. (MRNA) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Symbotic Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Symbotic Inc trades at $42.89 (market cap $5.19B). The key difference: Moderna, Inc. is far larger — about 4.5× Symbotic Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | SYM | |
|---|---|---|
Market Cap | $23.60B | $5.19B |
Sector | Health | Technology |
52-Week High | $81.80 | $87.30 |
52-Week Low | $22.36 | $38.57 |
Enterprise Value | $19.70B | $3.18B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
